Beaver-Visitec International to Acquire Malosa Medical

Source: Beaver-Visitec International

Beaver-Visitec International announced that it has acquired Malosa Medical, a manufacturer and supplier of single-use surgical instruments primarily for use in the field of ophthalmology. 

Terms of the transaction were not disclosed.

“Fueled by an aging population and an increased awareness and desire for eye care globally, the ophthalmology market has and will continue to experience robust growth. Malosa’s focus on innovation, along with its vertically integrated business model – through which it owns the production process from design to distribution – uniquely positions the company to adequately serve this expanding and evolving market,” Dana G. Mead, Jr. President and CEO of BVI, said in a company news release. “We are pleased to welcome Malosa employees to the BVI team and look forward to providing their comprehensive line of high-quality single-use ophthalmic instruments to a broader set of customers worldwide. Malosa’s product line is highly complementary to our single-use product portfolio and we are excited to work with the company to offer customers even more options for their patients.”

With a portfolio of more than 400 products, Malosa equips surgeons with convenient, sterilized, single-use packs that contain all the instruments and consumables required for specific ophthalmic procedures. The company’s cost-effective, high-quality instruments are designed for use in some of the most frequently performed procedures, including cataract surgery and intravitreal injection.

“We are thrilled to be joining forces with BVI and firmly believe that our combined offering of physician-preferred single-use ophthalmic instrumentation will continue to be highly valued by our customers and contribute to outstanding patient outcomes,” Gary Loran, Managing Director at Malosa, said in the news release. “BVI’s focus on building a strong brand that’s commitment to quality makes it an excellent strategic and cultural fit for Malosa. We believe the company is well-positioned for accelerated growth.”

BVI’s acquisition follows a series of key leadership appointments made throughout the last year. Most recently, the company named Shervin Korangy, formerly a senior executive at Novartis, Chief Financial Officer and Chief Strategy Officer. Other significant appointments include Dana G. Mead, Jr., a former Strategic Advisor and Partner at Kleiner Perkins Caufield & Byers (KPCB), as President and CEO; Ron Labrum, an industry veteran and the former President and CEO of medical device company Fenwal, as Chairman of the Board; and Darin Dixon, the former Vice President of Global Sales at ophthalmic device company AcuFocus Inc., as Vice President of U.S. Sales.

Related Content